2022

1. Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines

   Clinical and Translational Oncology, Vol. 24, Núm. 3, pp. 483-494